BSGM BioSig Technologies, Inc. Stock Quote

BSGM [NASD]

Index	-	P/E	-	EPS (ttm)	-0.82	Insider Own	6.90%	Shs Outstand	39.82M	Perf Week	-21.90%
Market Cap	38.07M	Forward P/E	-	EPS next Y	-0.77	Insider Trans	8.56%	Shs Float	35.31M	Perf Month	36.64%
Income	-29.70M	PEG	-	EPS next Q	-0.14	Inst Own	10.10%	Short Float	4.04%	Perf Quarter	-13.66%
Sales	0.10M	P/S	380.69	EPS this Y	49.10%	Inst Trans	-6.16%	Short Ratio	4.46	Perf Half Y	-32.78%
Book/sh	0.17	P/B	4.82	EPS next Y	24.00%	ROA	-200.50%	Target Price	5.00	Perf Year	-73.20%
Cash/sh	0.11	P/C	7.46	EPS next 5Y	-	ROE	-255.10%	52W Range	0.50 - 4.10	Perf YTD	-63.22%
Dividend	-	P/FCF	-	EPS past 5Y	8.70%	ROI	-269.30%	52W High	-80.80%	Beta	1.28
Dividend %	-	Quick Ratio	3.00	Sales past 5Y	-	Gross Margin	71.20%	52W Low	57.50%	ATR	0.12
Employees	50	Current Ratio	4.10	Sales Q/Q	-93.20%	Oper. Margin	-	RSI (14)	40.33	Volatility	13.32% 15.58%
Optionable	Yes	Debt/Eq	0.00	EPS Q/Q	38.40%	Profit Margin	-	Rel Volume	2.41	Prev Close	0.82
Shortable	Yes	LT Debt/Eq	0.00	Earnings	-	Payout	-	Avg Volume	320.40K	Price	0.79
Recom	2.00	SMA20	-21.36%	SMA50	1.47%	SMA200	-41.58%	Volume	138,346	Change	-3.98%

Mar-30-20

Initiated

ROTH Capital

Buy

Aug-30-22 09:37AM	BioSig Strengthens Marketing and Sales Teams, Appoints National Account Executives to Scale Commercial Growth GlobeNewswire
Aug-24-22 09:17AM	BioSig Places Second PURE EP System For Evaluation at Cleveland Clinic a Leading Medical Center of Excellence GlobeNewswire
Aug-17-22 09:15AM	BioSigs Cardiac Signal Processing Technology To Be Featured at Kansas City Heart Rhythm Symposium 2022 GlobeNewswire
Aug-16-22 09:47AM	BioSig Sees Positive Momentum from Sales Pipeline Growth GlobeNewswire +20.73%
Jul-21-22 10:00AM	BioSig Announces Physician-Initiated Research Protocol at The Kansas City Heart Rhythm Institute GlobeNewswire +6.16%
Jul-07-22 08:30AM	BioSig Announces Purchase Agreement with Kansas City Heart Rhythm Institute at Overland Park Regional Medical Center GlobeNewswire
Jun-29-22 05:45PM	BioSig Announces Closing of Public Offering of Common Stock GlobeNewswire -8.95%
Jun-24-22 09:30AM	BioSig Announces Pricing of Public Offering of Common Stock GlobeNewswire -26.29%
Jun-23-22 04:26PM	BioSig Announces Proposed Public Offering of Common Stock GlobeNewswire +13.64%
Jun-22-22 08:00AM	BioSig Announces New Evaluation Agreement for its PURE EP System with Cleveland Clinic GlobeNewswire +21.31%
May-31-22 09:25AM	Mesa Labs (MLAB) Surpasses Q4 Earnings and Revenue Estimates Zacks -16.32%
May-26-22 09:08AM	BioSig Advances its PURE System Commercial Launch to Medical Centers Nationwide GlobeNewswire
May-25-22 09:47AM	BioSigs PURE EP System to be Featured During EPLive 2022 GlobeNewswire
May-12-22 05:55PM	Neovasc (NVCN) Reports Q1 Loss, Misses Revenue Estimates Zacks
May-11-22 08:30AM	BioSig Technologies, Inc. Issues Shareholder Letter with Corporate Update on Recent Achievements GlobeNewswire +15.38%
May-05-22 06:55PM	Sensus Healthcare, Inc. (SRTS) Beats Q1 Earnings and Revenue Estimates Zacks
May-04-22 07:55AM	Idexx Laboratories (IDXX) Q1 Earnings Beat Estimates Zacks
Apr-19-22 09:10AM	BioSig to Present at Heart Rhythm 2022 GlobeNewswire
Apr-07-22 08:30AM	BioSig to Present at NobleCon18 Capital Markets Conference GlobeNewswire
Mar-29-22 10:06AM	BioSig Technologies, Inc. Partners with Summit Blue Capital to Provide Equipment Leasing Services GlobeNewswire +10.00%
Mar-23-22 08:00AM	BioSig Announces Closing of Public Offering of Common Stock GlobeNewswire
Mar-22-22 08:00AM	BioSig Technologies, Inc. Announces $3 Million Financing with Family Office GlobeNewswire +5.00%
Mar-16-22 09:00AM	BioSig Technologies, Inc. Appoints John Sieckhaus as Chief Operating Officer GlobeNewswire +10.08%
Feb-08-22 01:38PM	Smith, Moore & Co. Buys Simplify Hedged Equity ETF, BlackRock Science and Technology Trust ... GuruFocus.com
Jan-26-22 01:00PM	BioSig Awarded US Patent Claims for its PURE EP Noise-Filtering Technology GlobeNewswire
Jan-07-22 10:20AM	BioSig to Present at the 27th Annual International AF Symposium GlobeNewswire
Jan-06-22 08:30AM	BioSig to Present at the 24th Annual Virtual Needham Growth Conference GlobeNewswire
Dec-21-21 09:00AM	BioSig Technologies, Inc. Selects Access Strategy Partners to Accelerate Commercial Sales GlobeNewswire -9.89%
Dec-16-21 09:15AM	BioSig Expands Its Clinical Footprint In Florida GlobeNewswire
Dec-13-21 08:30AM	BioSig to Host Conference Call on December 21, 2021 GlobeNewswire
Dec-06-21 10:00AM	BioSig to Participate in the Benzinga All Access Event on December 14, 2021 GlobeNewswire
Dec-01-21 09:25AM	BioSig Technologies, Inc. Appoints Gray Fleming as Chief Commercial Officer GlobeNewswire
Nov-17-21 09:45AM	BioSig to Participate in the The Benchmark Company 10th Annual Discovery Conference GlobeNewswire +6.22%
Nov-16-21 09:52AM	BioSig Initiates Artificial Intelligence Development Program with Technion Israel Institute of Technology GlobeNewswire +13.50%
Nov-11-21 02:45PM	BioSig to Host Live Roundtable Webinar to Discuss Clinical Data Delivered With Its Signal Processing Technology For Arrhythmia Care GlobeNewswire
Nov-10-21 09:20AM	BioSig Adds To Its Clinical Footprint In Texas GlobeNewswire
Nov-08-21 11:30AM	BioSig Installs its Signal Processing Technology for Arrhythmia Care at a Leading Hospital in Boston GlobeNewswire
Nov-04-21 11:00AM	BioSig Expands its Installation Base in Texas GlobeNewswire
Nov-01-21 12:30PM	BioSig Increases Case Volume Estimates GlobeNewswire +20.37%
Oct-13-21 09:01AM	Clinical Data Published in the Journal of Cardiovascular Electrophysiology Could Be Important for This Stock Benzinga
Oct-12-21 09:15AM	BioSigs PURE EP System to be Featured in a Live Patient Case During Annual International Symposium on Ventricular Arrhythmias GlobeNewswire
Oct-07-21 12:41PM	BioSig Inks Manufacturing Deal with Plexus Corp Benzinga
Oct-04-21 08:30AM	Clinical Data Acquired by the PURE EP System Published in the Journal of Cardiac Electrophysiology GlobeNewswire -6.71%
Sep-28-21 09:15AM	BioSig Selects Plexus Corp. as its Manufacturing Partner GlobeNewswire -6.89%
Sep-23-21 09:47AM	BioSig's PURE EP Aims to Address Unmet Needs of Afib Patients Benzinga
06:43AM	Can BioSig Technologies (NASDAQ:BSGM) Afford To Invest In Growth? Simply Wall St.
Sep-21-21 10:30AM	BioSig Technologies, Inc. Appoints Medical Device Industry Leader to its Board of Directors GlobeNewswire
Sep-17-21 07:40AM	BioSig Expands in Electrophysiology with St. Elizabeth's Medical Center Evaluation Benzinga
Sep-13-21 08:00AM	BioSig Increases Installation Footprint Adding St. Elizabeths Medical Center to Roster of Premium Medical Institutions Utilizing the PURE EP System GlobeNewswire
Sep-02-21 09:41AM	4 Penny Stocks Insiders Are Buying Benzinga
Aug-31-21 10:00AM	BioSig Confirmed as a Participant of The Mark E. Josephson Twenty-Eight Annual State-of-the-Art Arrhythmia Virtual Symposium GlobeNewswire
Aug-19-21 11:00AM	BioSigs Signal Processing System for Arrhythmia Care To Be Featured At The Kansas City Heart Rhythm Symposium GlobeNewswire -8.14%
Jul-20-21 02:00PM	BioSig To Host Presentations from Physician Users of its Signal Processing System for Arrhythmia Care during the annual Heart Rhythm 2021 convention GlobeNewswire
Jul-13-21 02:30PM	BioSig Latest Installation Broadens Clinical Footprint for its Signal Processing Technology for Electrophysiology GlobeNewswire
Jul-12-21 10:30AM	BioSig to Host Conference Call to Unblind Clinical Data Collected with its Signal Processing Technology for Arrhythmia Care GlobeNewswire
Jul-07-21 04:10PM	BioSig Announces Closing of Public Offering of Common Stock GlobeNewswire -7.11%
09:36AM	BioSig Enters the New York Market with Its Signal Processing Technology for Electrophysiology GlobeNewswire
Jul-06-21 09:44AM	Mayo Clinic Purchases BioSig's PURE EP for use at its Phoenix Location Benzinga -5.52%
Jul-02-21 09:37AM	BioSig Technologies Raises $10M Via Equity Issued At $4/Share Benzinga
08:15AM	BioSig Announces Pricing of Public Offering of Common Stock GlobeNewswire
Jul-01-21 04:05PM	BioSig Announces Proposed Public Offering of Common Stock GlobeNewswire +12.69%
Jun-30-21 10:03AM	BioSig Completes 1000 Patient Cases with its Signal Processing System for Electrophysiology Benzinga -6.31%
09:35AM	BioSig Completes 1000 Patient Cases with its Signal Processing System for Electrophysiology GlobeNewswire
Jun-28-21 09:45AM	BioSigs Signal Processing Technology for Electrophysiology To Be Featured During 2021 Stanford Biodesign New Arrhythmia Technologies Retreat GlobeNewswire +15.56%
Jun-22-21 10:06AM	BioSigs Signal Processing System for Electrophysiology Featured in Two Clinical and Scientific Presentations during the annual Heart Rhythm 2021 convention GlobeNewswire
Jun-15-21 02:14PM	Where Do Hedge Funds Stand On BioSig Technologies, Inc. (BSGM)? Insider Monkey
08:30AM	BioSig Technologies, Inc. to Present New Clinical Data at Heart Rhythm 2021 Annual Convention GlobeNewswire
Jun-07-21 08:30AM	BioSig Technologies, Inc. to Present at the LD Micro Invitational XI Virtual Event GlobeNewswire +8.45%
May-28-21 10:30AM	BioSig Technologies, Inc. to Present at the Jefferies Virtual Healthcare Conference GlobeNewswire
May-24-21 09:44AM	The Power and Precision of BioSig's PURE EP System in the Electrophysiology (EP) Market Benzinga
May-21-21 09:15AM	BioSig Technologies, Inc. to Present at the Oppenheimer MedTech, Tools & Diagnostics Summit GlobeNewswire
May-04-21 06:28PM	BioSig Sees Increased Case Volume from Expanding Base of Medical Centers Using Its Proprietary Signal Processing System Benzinga
09:15AM	BioSig Sees Increased Case Volume from Expanding Base of Medical Centers Using Its Proprietary Signal Processing System GlobeNewswire
May-03-21 12:00PM	BioSig Technologies, Inc. Invited to Present at Wall Street Conference GlobeNewswire
01:56AM	Is BioSig Technologies, Inc.'s (NASDAQ:BSGM) Shareholder Ownership Skewed Towards Insiders? Simply Wall St.
Apr-27-21 09:30AM	BioSigs PURE EP(tm) System Evaluated with Patients at Mayo Clinic in Arizona GlobeNewswire
Apr-15-21 11:45AM	BioSig Expands Commercial Team in Two Strategic Regions GlobeNewswire
Apr-14-21 09:29AM	BioSig Launches Enhanced Signal Processing Capabilities for Advanced Cardiac Signal Analysis Through its Electrophysiology Platform GlobeNewswire
Apr-13-21 09:32AM	BioSig Completes Enrollment in the PURE EP 2.0 Clinical Study GlobeNewswire
Apr-09-21 09:32AM	BioSig Invited to Join Alliance for Artificial Intelligence in Healthcare (AAIH) GlobeNewswire
Apr-08-21 09:32AM	EP Lab Digest Features Physician Experience with BioSigs Cardiac Signal Acquisition Technology GlobeNewswire +6.41%
Apr-06-21 09:45AM	BioSig lands Commercial Sales to Leading Hospital System GlobeNewswire
Apr-05-21 10:00AM	BioSig Technologies, Inc. to Present at the 20th Annual Needham Virtual Healthcare Conference GlobeNewswire +6.03%
Mar-30-21 08:30AM	BioSig Awarded U.S. Patent Claims for the Noise-Filtering Methods for its Signal Processing Technology GlobeNewswire +5.58%
Mar-29-21 09:15AM	BioSig Issues Shareholder Letter with Corporate Update on Recent Achievements and Anticipated Milestones for 2021 GlobeNewswire
Mar-19-21 12:15PM	BioSig CEO Kenneth L. Londoner to Present at the Benzinga Biotech Small Cap Conference GlobeNewswire
Mar-10-21 05:30PM	BioSig CEO Kenneth L. Londoner to Present at the Oppenheimer 31st Annual Healthcare Conference GlobeNewswire
Mar-09-21 04:45PM	BioSig CEO Kenneth L. Londoner to Present at the 33rd Annual Virtual ROTH Conference GlobeNewswire +9.16%
Mar-05-21 09:44AM	The Future of Medicine is Here: Bioelectronic Medicine Benzinga
Mar-04-21 09:15AM	BioSig Awarded U.S. Patent Claims for its NeuroClear Subsidiary GlobeNewswire
Feb-16-21 08:45AM	BioSig Appoints Brenda Castrodad to Lead Human Resources GlobeNewswire -5.25%
Feb-11-21 08:30AM	Global Cardiovascular Devices Market Now Project to Exceed $71 Billion By 2027 PR Newswire +5.34%
Feb-10-21 10:00AM	Major Medical Centers Enter into Installation Agreements for Evaluation of BioSig PURE EP Systems GlobeNewswire
Feb-08-21 08:35AM	Small and Microcap Company Investor Presentations Now Available for On-Demand Viewing PR Newswire
Feb-02-21 08:00AM	BioSig and Mayo Clinic Collaborate on New R&D Program to Develop Transformative AI and Machine Learning Technologies for its PURE EP System GlobeNewswire
Jan-28-21 08:35AM	Live Investor Conference & Webinar: Small and Microcap Company Showcase on February 4th PR Newswire
Jan-27-21 04:30PM	BioSig CEO Kenneth L. Londoner to Present at the Virtual Investor Conference Small and Microcap Showcase GlobeNewswire
Jan-15-21 09:32AM	BioSig to Present at the 26th Annual International AF Symposium GlobeNewswire -8.71%
Jan-14-21 09:32AM	BioSig PURE EP System Featured in the Editorial of EP Lab Digest GlobeNewswire
Jan-13-21 01:35PM	Why Vuzix Stock Popped Today Motley Fool +8.01%

BioSig Technologies, Inc., together with its subsidiaries, operates as medical device company. The company's proprietary product includes precise uninterrupted real-time evaluation of electrograms electrophysiology (PURE EP) system, a signal processing platform that combines hardware and software to address known challenges associated to signal acquisition that enables electrophysiologists to see signals and analyze in real-time. It also focuses on enhancing intracardiac signal acquisition and diagnostic information for the procedures of atrial fibrillation, as well as is designed to address long-standing limitations that slow and disrupt cardiac catheter ablation procedures. The company has a research agreement with University of Minnesota to develop novel therapies to treat sympathetic nervous system diseases; and a strategic collaboration with the Mayo Foundation for Medical Education and Research to develop an AI-and machine learning software solution for PURE EP systems. BioSig Technologies, Inc. was incorporated in 2009 and is headquartered in Westport, Connecticut.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
LONDONER KENNETH L	Chief Executive Officer	Sep 07	Buy	0.86	7,250	6,207	1,844,354	Sep 08 09:00 AM
LONDONER KENNETH L	Chief Executive Officer	Sep 06	Buy	1.02	5,900	6,001	1,837,806	Sep 07 10:28 AM
LONDONER KENNETH L	Chief Executive Officer	Sep 02	Buy	1.08	6,400	6,910	1,831,204	Sep 07 10:28 AM
LONDONER KENNETH L	Chief Executive Officer	Sep 01	Buy	1.08	17,240	18,704	1,824,804	Sep 02 12:51 PM
CHAUSSY STEVE	Chief Financial Officer	Sep 01	Buy	1.13	11,425	12,929	1,051,553	Sep 02 09:35 AM
LONDONER KENNETH L	Chief Executive Officer	Aug 30	Buy	1.08	9,000	9,740	1,807,564	Aug 31 10:05 AM
Sieckhaus John	Chief Operating Officer	Aug 30	Buy	1.07	5,000	5,335	65,000	Sep 01 06:00 AM
LONDONER KENNETH L	Chief Executive Officer	Aug 29	Buy	1.09	8,850	9,618	1,798,564	Aug 31 10:05 AM
LONDONER KENNETH L	Chief Executive Officer	Aug 26	Buy	1.13	8,276	9,381	1,789,714	Aug 29 09:44 AM
LONDONER KENNETH L	Chief Executive Officer	Aug 25	Buy	1.19	8,450	10,033	1,781,438	Aug 29 09:44 AM
Gallagher Patrick Joseph	Director	Aug 24	Buy	1.16	17,000	19,720	100,000	Aug 25 02:26 PM
Sieckhaus John	Chief Operating Officer	Aug 24	Buy	1.13	10,000	11,347	60,000	Aug 25 06:02 AM
Fleming Gray	Chief Commercial Officer	Aug 24	Buy	1.18	36,036	42,522	36,036	Aug 31 01:34 PM
LONDONER KENNETH L	Chief Executive Officer	Aug 23	Buy	1.09	12,000	13,040	1,772,988	Aug 24 11:01 AM
CHAUSSY STEVE	Chief Financial Officer	Aug 22	Buy	1.13	8,000	9,016	1,040,128	Aug 24 10:17 AM
LONDONER KENNETH L	Chief Executive Officer	Aug 19	Buy	1.00	10,000	10,030	1,760,988	Aug 22 08:48 AM
LONDONER KENNETH L	Chief Executive Officer	Aug 17	Buy	0.97	13,100	12,659	1,750,988	Aug 19 09:30 AM
LONDONER KENNETH L	Chief Executive Officer	Aug 16	Buy	0.90	25,100	22,602	1,737,888	Aug 17 11:00 AM
LONDONER KENNETH L	Chief Executive Officer	May 25	Buy	1.15	9,300	10,695	1,712,788	May 26 11:15 AM
LONDONER KENNETH L	Chief Executive Officer	May 24	Buy	1.10	8,744	9,601	1,703,488	May 25 08:30 AM
LONDONER KENNETH L	Chief Executive Officer	May 23	Buy	1.14	11,850	13,539	1,694,744	May 24 01:51 PM
LONDONER KENNETH L	Chief Executive Officer	May 20	Buy	1.13	3,650	4,124	1,682,894	May 24 01:51 PM
LONDONER KENNETH L	Chief Executive Officer	Sep 21	Buy	2.85	5,950	16,958	1,719,244	Sep 29 01:56 PM
LONDONER KENNETH L	Chief Executive Officer	Sep 20	Buy	2.81	2,636	7,407	1,713,294	Sep 29 01:56 PM

open in yahoo | open in reuters | open in marketwatch | open in google

Upgrade your FINVIZ experience